Publication of HMPC Documents on Essential Oils

Recommendation
10/11 September 2025
At the beginning of May 2014, the EMA's HMPC (Committee on Herbal Medicinal Products) published the final "Reflection Paper" on quality of essential oils used for the manufacture of herbal medicinal products/traditional herbal medicinal products. The document was adopted on 25 March by the HMPC.
This "Reflection Paper" should help consider aspects related to the nature and the specific production processes of essential oils.
Products with essential oils belong to herbal preparations. So far, the requirements on essential oils hadn't been sufficiently addressed in the existing guidelines.
Moreover, the current HMPC quality guidelines don't take into consideration the definitions of essential oils as laid down in the European Pharmacopoeia (Ph. Eur.).
Essential oils used as API in herbal products lead to - from a regulatory view - a wide range of questions, especially as the current guidelines incompletely depict the specific aspects of essentials oils.
In addition, a Q&A document containing questions and answers on herbal medicinal products/traditional herbal medicinal products was published on 30 April 2014. Four new questions and answers about essential oils have been added to this Q&A document.
For more detailed information please see the complete "Reflection paper on quality of essential oils as active substances in herbal medicinal products/taditional herbal medicinal products" as well as the extended Q&A document "Questions & answers on quality of herbal medicinal products/traditional herbal medicinal products".
Related GMP News
16.07.2025Inadequate Sampling and Component Testing Highlighted in FDA Warning Letter
16.07.2025EMA publishes new Product-Specific Bioequivalence Guidance
16.07.2025Revision of USP Chapter <1039> Chemometrics Published for Comments
16.07.2025Proposal for new USP Chapter <318> NMR Monomer Ratio Determination for Lactide-Glycolide Polymers
16.07.2025New USP Chapter <1221> on Ongoing Procedure Performance Verification (OPPV) Published for Comment
02.07.2025FDA Warning Letter: Missing Testing, No Stability Data, and Inadequate Raw Material Controls